Thursday, October 15, 2020

Remdesivir Didn't Cut Hospital Stay Or Mortality In Covid Patients: WHO

Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.

No comments:

Post a Comment

Amber Discovered For the First Time in Antarctica: What You Need to Know

The discovery of amber in Antarctica has been reported for the first time, as detailed in a recent study published in Antarctic Science. Dr...